← SynDRA
ICARITIN
SynDRA canonical compound SYN0018613 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PDE5A |
|---|
| Mechanism of action | PPAR receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- PPAR receptor antagonist
- ESR1 MODULATOR
Cross-references
Synonyms
- SGN-162
- SGN162
- UNII-UFE666UELY
- UFE666UELY
- CHEMBL498485
- 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one
- 3,5,7-Trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
- Icartin
- Anhydroicaritin
- AC1NSXIV
- Icaritin(Anhydroicaritin)
- MLS006010055
- BIDD:ER0021
- SCHEMBL4223542
- Icaritin, >
- DTXSID00152154
- MolPort-020-006-012
- TUUXBSASAQJECY-UHFFFAOYSA-N
- HY-N0678
- ZINC14762797
- BDBM50272527
- AKOS015896858
- CS-3679
- DB12672
- NCGC00345813-01
- AK168251
- SMR004701218
- RefChem:147599
- DTXCID4074645
- MFCD22422519
- Icaritin (Standard)
- Icaritin(Anhydroicaritin)?
- ICARITIN [WHO-DD]
- orb1304239
- orb3140507
- Icaritin, >=98% (HPLC)
- SCHEMBL29360642
- HY-N0678R
Look up ICARITIN in the interactive SynDRA portal →